Polatuzumab-vedotin
from OncoPharm Hosted by John Bossaer
A newly approved drug for relapsed/refractory diffuse large B-cell lymphoma is discussed as well as PBR.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OncoPharm?
This episode is 13 minutes long.
When was this OncoPharm episode published?
This episode was published on June 13, 2019.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.